- Home
- GSK vs SLB Comparison
GSK vs SLB Comparison
Compare GSK & SLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- SLB
- Stock Information
- Founded
- GSK 1715
- SLB 1926
- Country
- GSK United Kingdom
- SLB United States
- Employees
- GSK 70200
- SLB N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- SLB Oilfield Services/Equipment
- Sector
- GSK Health Care
- SLB Energy
- Exchange
- GSK Nasdaq
- SLB Nasdaq
- Market Cap
- GSK 68.6B
- SLB 59.6B
- IPO Year
- GSK N/A
- SLB N/A
- Fundamental
- Price
- GSK $33.60
- SLB $36.99
- Analyst Decision
- GSK Hold
- SLB Strong Buy
- Analyst Count
- GSK 5
- SLB 18
- Target Price
- GSK $45.50
- SLB $59.06
- AVG Volume (30 Days)
- GSK 4.3M
- SLB 12.3M
- Earning Date
- GSK 02-05-2025
- SLB 01-17-2025
- Dividend Yield
- GSK 4.63%
- SLB 2.99%
- EPS Growth
- GSK N/A
- SLB 8.00
- EPS
- GSK 0.81
- SLB 3.11
- Revenue
- GSK $41,966,224,352.00
- SLB $35,995,000,000.00
- Revenue This Year
- GSK $6.50
- SLB $10.49
- Revenue Next Year
- GSK $4.54
- SLB $5.38
- P/E Ratio
- GSK $20.12
- SLB $11.84
- Revenue Growth
- GSK 5.59
- SLB 12.40
- 52 Week Low
- GSK $32.83
- SLB $36.52
- 52 Week High
- GSK $45.93
- SLB $55.69
- Technical
- Relative Strength Index (RSI)
- GSK 40.58
- SLB 22.20
- Support Level
- GSK $33.58
- SLB $40.47
- Resistance Level
- GSK $34.56
- SLB $41.79
- Average True Range (ATR)
- GSK 0.54
- SLB 1.05
- MACD
- GSK 0.01
- SLB -0.58
- Stochastic Oscillator
- GSK 17.28
- SLB 0.27
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About SLB Schlumberger N.V.
SLB is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.